Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue
name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers Doppler Probes that is used to measure a patient's blood flow and fluid status directly from the descending aorta during surgery and critical care; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure wave algorithm for deriving haemodynamic parameters. The company's products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom. The company trades on AIM exchange marketplace. The company headquarter is located in United Kingdom. The company was established in the 2004. The company's ISIN is GB0059337583. As of writing, the company status seems to be inactive, which indicates it may not be actively trading on the stock exchanges and may be delisted/merged/suspended/renamed.
| Ticker | DEMG |
| Long Name | Deltex Medical Group PLC |
| Short Name | Deltex Medical Group |
| Sector | Healthcare |
| Subsector | Medical Devices |
| Subsector 2 | Health Care |
| Currency | GBX |
| ISIN | GB0059337583 |